Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical pregabalin cream for chronic vulvo-vaginal pain
ACTRN12614001153606Phase 3Not yet recruiting
- Sponsor
- Dr Jane Manning
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vulvodynia comparing Pregabalin cream with Placebo cream (2 arms). Primary endpoints: Vulvo-vaginal pain severity at 12 weeks, Patient Global Impression of Change at 6 weeks and 1 more. Planned start Nov 2014; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
vulvodynia
Beyond the preview
Go deeper on ACTRN12614001153606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001153606.